• Skip to primary navigation
  • Skip to main content
  • Skip to footer
Synergy Spine Solutions

Synergy Spine Solutions

Restoring Balance to Motion Preservation

  • Synergy Disc
    • Clinical Research
  • Company Overview
    • About Synergy Spine Solutions
    • Clinical Research
    • Patents
    • Publications
    • News
  • Distributors
  • Contact

OrthoCG

2024 in review: a year of milestones and momentum at Synergy Spine Solutions

January 13, 2025 by OrthoCG

The past year has been one of transformative growth and accomplishment at Synergy Spine Solutions. From securing pivotal funding to achieving significant clinical trial milestones and expanding our global footprint, we are proud to share the highlights of 2024. Keep reading to discover how we reaffirmed our commitment to elevating the standard of care in […]

Filed Under: Press Releases

Synergy Spine Solutions announces completion of patient enrollment in the Synergy Disc® 2-Level IDE clinical trial

September 25, 2024 by OrthoCG

LOUISVILLE, Colo., Sept. 25, 2024 /PRNewswire/ — Synergy Spine Solutions Ltd, an innovative orthopedic medical device developer focused on artificial cervical disc replacement, today announced that it has completed patient enrollment in its U.S. 2-Level IDE clinical trial. Conducted under a U.S. Investigational Device Exemption (IDE), the 2-Level trial will evaluate the safety and effectiveness of the Synergy […]

Filed Under: Press Releases

Synergy Spine Solutions Announces $30M Financing 

January 31, 2024 by OrthoCG

Synergy Spine Solutions Logo

LOUISVILLE, Colorado, January 31, 2024 – Synergy Spine Solutions, an innovative medical device developer focused on artificial cervical disc replacement, announced today that it has closed on a significant equity financing of $30 million.  The Series A financing was led by a new institutional investor, Amzak Health, and joined by other investors. The proceeds will […]

Filed Under: Press Releases

Synergy Spine Solutions Announces Strategic Collaboration with DePuy Synthes UK

September 20, 2023 by OrthoCG

Synergy Spine & Depuy Logo

Synergy Spine Solutions, an innovative orthopaedic medical devices developer focused on artificial cervical disc replacement, today announced it has entered into a sales agency agreement with DePuy Synthes Spine (DPS) to expand access to the company’s marquis technology, the Synergy Disc®, in the United Kingdom.  The Synergy Disc® is the only artificial cervical disc with a 6° lordotic […]

Filed Under: Press Releases

Synergy Spine Solutions announces partnership with Ample Healthcare to distribute the Synergy Disc in Malaysia

July 28, 2023 by OrthoCG

Synergy x Ample Healthcare Logos

Synergy Spine Solutions is pleased to announce a new partnership with leading independent medical device specialists Ample Healthcare, to distribute the Synergy Disc in Malaysia. Based in Kuala Lumpur and with a focus in spine and orthopaedic surgery, Ample Healthcare was launched in 2020 with the objective of providing international partners access to the Malaysian market.  The […]

Filed Under: Press Releases

Synergy Spine Solutions Announces First Patient Enrolled in the Synergy Disc® 2-Level IDE Trial

June 29, 2023 by OrthoCG

Synergy Spine Solutions

Synergy Spine Solutions Ltd, an innovative orthopaedic medical device developer focused on artificial cervical disc replacement, today announced it has enrolled the first patient in its U.S. IDE 2-Level clinical trial. Conducted under a U.S. Investigational Device Exemption (IDE), the 2-Level trial will evaluate the safety and effectiveness of the Synergy Disc® artificial cervical disc […]

Filed Under: Press Releases

  • Page 1
  • Page 2
  • Go to Next Page »

Footer

Phone: +1.647.692.3493
Email: info@synergyspinesolutions.com

United States Office
357 S. McCaslin Blvd, Suite 120
Louisville, CO 80027, USA

Canada Office
100 Pinebush Road,
Cambridge ON N1R 8J8, Canada

  • Publications
  • Patents
  • Company Overview
  • Distributors
  • Synergy Disc
  • Contact

Copyright © 2025 Synergy Spine Solutions Inc. All Right Reserved. · Privacy Policy
USA Investigational Device Statement: Caution: Investigational Device. Limited by United States law to Investigational use.
230-00001 REVE